Trials / Completed
CompletedNCT05195216
Psychosocial Factors and Quality of Life in the Effect of Fear of COVID-19 With Cystic Fibrosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 128 (actual)
- Sponsor
- Elif Kabasakal · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study; The COVID-19 pandemic is to investigate the effects of COVID-19 fear levels of patients with cystic fibrosis on the psychosocial and quality of life levels of individuals.
Detailed description
After individuals were informed about the study, it was administered to individuals who gave written informed consent.This study was carried out on individuals with cystic fibrosis and healthy individuals who meet the eligibility requirements, through online forms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Survey Form, The Hospital Anxiety and Depression Scale, The Fear of COVID-19 Scale,World Health Organization Quality of Life Scale- Bref Form | Online questionnaires were administered to individuals. |
Timeline
- Start date
- 2021-11-20
- Primary completion
- 2021-11-30
- Completion
- 2021-12-25
- First posted
- 2022-01-18
- Last updated
- 2022-01-18
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05195216. Inclusion in this directory is not an endorsement.